Patents by Inventor Catherine A. Fleener

Catherine A. Fleener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD86 and CD80 receptor competition assays
    Publication number: 20120077207
    Abstract: The present invention discloses a method for assaying the binding of L104EA29YIg to a receptor. The receptor is preferably CD86 or CD80. The present invention also discloses antibodies to be used in the assay, as well as hybridomas expressing the antibodies.
    Type: Application
    Filed: January 7, 2009
    Publication date: March 29, 2012
    Inventors: Catherine A. Fleener, Robert M. Townsend, Francisco Leon
  • CD86 and CD80 receptor competition assays
    Patent number: 7510844
    Abstract: The present invention discloses a method for assaying the binding of L104EA29YIg to a receptor. The receptor is preferably CD86 or CD80. The present invention also discloses antibodies to be used in the assay, as well as hybridomas expressing the antibodies.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: March 31, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Robert M. Townsend, Catherine A. Fleener, Francisco Leon
  • CD86 and CD80 receptor competition assays
    Publication number: 20070172895
    Abstract: The present invention discloses a method for assaying the binding of L104EA29YIg to a receptor. The receptor is preferably CD86 or CD80. The present invention also discloses antibodies to be used in the assay, as well as hybridomas expressing the antibodies.
    Type: Application
    Filed: January 22, 2007
    Publication date: July 26, 2007
    Inventors: Catherine Fleener, Robert Townsend, Francisco Leon